Valuation : Vitrolife AB

Market Cap 12.87B 1.34B 1.16B 1.09B 995M 1.86B 127B 1.87B 4.99B 65.14B 5.05B 4.94B 210B P/E 2026 *
26.1x
P/E 2027 * 21.1x
Enterprise Value 13.41B 1.4B 1.21B 1.14B 1.04B 1.94B 132B 1.95B 5.21B 67.92B 5.27B 5.15B 219B EV / Sales 2026 *
3.88x
EV / Sales 2027 * 3.46x
Free-Float
54.39%
Yield 2026 *
1.16%
Yield 2027 * 1.33%
1 day-1.50%
1 week-0.52%
Current month+0.16%
1 month+5.67%
3 months-2.11%
6 months+1.39%
Current year-30.66%
1 week 93.05
Extreme 93.05
96.7
1 month 87
Extreme 87
98.1
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-0.52%-29.21%-37.91% 1.34B
+0.23%-0.06%+163.05%+361.04% 21.66B
-2.24%-1.33%-35.83%-22.38% 10.16B
-0.90%+1.80%+361.68%+15.91% 8.16B
-0.99%-2.18%-31.03% - 7.08B
-0.01%+0.20%+87.61%+50.03% 6.59B
+2.34%-1.27%-20.56%-16.40% 6.03B
-1.82%-1.64%-8.72%-21.79% 4.33B
-0.62%-0.38%+76.78%+83.40% 4.22B
+1.82%-0.27%-18.22%-29.00% 2.81B
Average -0.37%-0.43%+54.55%+42.54% 7.24B
Weighted average by Cap. -0.35%-0.26%+90.48%+123.71%

Financials

2026 *2027 *
Net sales 3.46B 361M 311M 293M 267M 500M 34.12B 501M 1.34B 17.51B 1.36B 1.33B 56.4B 3.71B 388M 333M 314M 287M 536M 36.59B 538M 1.44B 18.77B 1.46B 1.42B 60.47B
Net income 493M 51.48M 44.3M 41.68M 38.07M 71.23M 4.86B 71.42M 191M 2.49B 193M 189M 8.03B 609M 63.63M 54.75M 51.52M 47.06M 88.03M 6.01B 88.27M 236M 3.08B 239M 234M 9.93B
Net Debt 549M 57.39M 49.38M 46.46M 42.44M 79.4M 5.42B 79.62M 213M 2.78B 216M 211M 8.96B -26.74M -2.79M -2.4M -2.26M -2.07M -3.87M -264M -3.88M -10.38M -135M -10.49M -10.27M -436M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
04/09/26 SEK 95.00 -1.50% 70,182
03/09/26 SEK 96.45 +2.01% 268,907
02/09/26 SEK 94.55 +0.16% 78,991
01/09/26 SEK 94.40 -0.47% 177,806
31/08/26 SEK 94.85 -0.68% 174,419
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
95.00SEK
Average target price
129.60SEK
Spread / Average Target
+36.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock